Select the drug indication to add to your list


Only 4 drugs may be compared at once

Generic Name and Formulations:

Hepatitis A vaccine, inactivated 25Units per 0.5mL (pediatric/adolescent), or 50Units per 1mL (adult); susp for IM inj; aluminum adsorbed; preservative-free.

Select therapeutic use:

Indications for VAQTA:

Hepatitis A immunization.


≥19 yrs: 1mL IM at elected date and booster dose (1mL IM) 6–18 months later.


<12 months: not recommended. 1–18 yrs: 0.5mL IM at elected date and booster dose (0.5mL IM) 6–18 months later.


Have epinephrine (1:1000) available. Latex allergy. Inject into deltoid muscle, preferably at least 2 weeks before expected exposure. If given with immune globulin, use separate syringe and different site. Fever. Malignancies. Immunocompromised (may have suboptimal response). Bleeding disorders. Pregnancy (Cat.C). Nursing mothers.


Immunosuppressives may reduce efficacy. Concomitant vaccines, immune globulins: see literature.

Adverse Reactions:

Injection site reactions (esp. pain, tenderness), headache, fever, GI upset, myalgia, abdominal pain, rash, pharyngitis and other upper respiratory tract effects.

How Supplied:

Prefilled syringes (0.5mL, 1mL)—1, 5; Single-dose vials (0.5mL)—1, 10; Single-dose vials (1mL)—1, 5, 10